Medullary thyroid carcinoma occurs in 25% of the dominant component of hereditary multiple endocrine neoplasia type 2 (MEN2); mutations of the proto-oncogene RET are the most frequently involved in cancer pathogenesis, but there are many other mutation patterns [13,18]. The gene discussed is RET; the disease is multiple endocrine neoplasia type 2.